Small molecules binders of SRA domain of UHRF1 would be useful components of molecular toolbox for the study of cancer epigenetics, cell signaling pathways, and most significantly as lead molecules for the development of anti-cancer therapeutics. The gene discussed is UHRF1; the disease is cancer.